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Abstract 
Introduction: Kasabach-Merritt syndrome (KMS) is a life-threatening disease. We describe a 
combined medical and multistep, endovascular embolization that was successfully performed 
with surgery. Case Report: A 40-day-old female baby was referred because of an infiltrating 
pelvic mass. Blood tests showed severe anemia and thrombocytopenia with consumptive 
coagulopathy. The clinical aspect was pathognomonic for KMS. Administration of steroids 
and chemotherapy were started and coagulation parameters were normalized with tumor 
volume regression. Three months later, elective surgical treatment became possible, and 
dissection and ligature of the left internal iliac artery and sacral artery were performed. The 
main arterial supply of the mass was embolized with Spongostan
®
. Two months later, a 
second hybrid approach was adopted for embolization of the main vascular supply of the 
tumor occupying the left thigh. Via a third contralateral hybrid femoral approach and under 
fluoroscopy, selective catheterization of the left profunda femoris artery was performed. The 
arterial feeder of the tumor, localized at the left gluteus, was seen on a CT scan 2 months 
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later and was embolized with Onyx-18. Conclusion: Chemotherapy and a tailored hybrid 
approach comprising repeated endovascular embolizations seem to be a safe treatment in 
cases of unresectable and life-threatening tumors in small babies. 
© 2014 S. Karger AG, Basel 
Introduction 
Kaposiform hemangioendothelioma (KHE) is a rare vascular tumor of infancy and child-
hood, with extremely aggressive behavior locally [1]. When associated with thrombocytope-
nia and consumptive coagulopathy, it is known as Kasabach-Merritt syndrome (KMS) [2]. 
Management of abdominopelvic KMS in infants is challenging due its infiltrating nature 
and risk of bleeding, and it presents a high mortality rate in newborns [3]. Steroids, 
chemotherapy and radiotherapy are not sufficient to induce total regression. Percutaneous 
embolization is feasible in children, but remains technically extremely difficult and 
dangerous in neonates and in small babies [4]. The treatment of choice is decided upon 
presentation of KMS in each individual patient, especially those in the first year of life. 
We describe a combined medical and repeated endovascular embolization using a tai-
lored surgical approach in a small baby affected with KMS. This treatment could represent 
an innovative multidisciplinary approach in infancy. 
Case Report 
A 40-day-old female baby was referred to our division for an abdominal mass that had 
been diagnosed in another institution. Upon physical examination, she presented a pelvic 
mass extending to the gluteus and left thigh. Left lower-extremity paralysis was noted. Blood 
tests showed severe anemia and thrombocytopenia. In the following hours, her hematologic 
status worsened due to consumptive coagulopathy and the increasing volume of the mass. 
The CT scan done on admission showed an infiltrating pelvic mass (12 × 8 × 6 cm) extending 
through the sciatic foramen to the left gluteus and thigh (fig. 1). The clinical aspect was 
pathognomonic of KMS. 
Transfusion, steroids and chemotherapy (vincristine, prednisone, rapamycin and cyclo-
phosphamide) were started immediately. Coagulation parameters were normalized and the 
patient stabilized. Three months later, regression of the tumor volume (8 × 4 × 3 cm) was 
observed and interventional treatment became possible. Surgical dissection and ligature of 
the left internal iliac artery and sacral artery were performed. The main arterial supply of 
the pelvic mass was then embolized using a gelatin sponge (Spongostan Haemostatic®) 
under the fluoroscopy guidance of a portable C-arm tube in the operating room. At the 
control, complete regression of the pelvic mass and its vascularization were seen on the CT 
scan (fig. 2). A clear sensitive-motor improvement was observed. 
Three months later, a second, similar, combined approach for the tumor occupying the 
left thigh was adopted. Surgical dissection of the left femoral artery and then partial 
embolization of the remaining tumor using a gelatin sponge (Spongostan Haemostatic) were 
successfully performed (fig. 3a). A third selective embolization of the arterial supply of the 
remaining tumor localized at the left gluteus region was planned for 2 months afterwards. 
A hybrid approach to the contralateral femoral artery was achieved in the angiographic 
room using Philips Allura flat-panel angiography. The right femoral artery was dissected and 
a 4-french, valved introducer was placed in the right common femoral artery. The contrala-
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teral, left lower-limb angiography done with a 4-french, shaped Cobra catheter (Glidecath, 
Terumo, Tokyo, Japan) showed the main supply of the hypervascular tumor in the gluteus 
(fig. 3b). Using a 2.7-french Echelon (EV3) microcatheter, selective catheterization of the 
profunda femoris artery feeders supplying the tumor was performed. Angiographic 
devascularization was achieved under fluoroscopy after injection of 0.8 ml of a nonadhesive, 
liquid glue, Onyx-18 (ethylene vinyl alcohol copolymer, Micro Therapeutics, Irvine, Calif., 
USA) (fig. 3c). Four months after treatment, the patient was stable. 
Discussion 
KHE is a rare vascular tumor that occurs nearly exclusively during childhood and the 
teenage years, with an equal sex distribution. Half of the lesions are present at birth, but 
58% of the cases of KHE develop during infancy, 32% in children between the ages of 1 and 
10 years and 10% in children older than 11 years [4]. KHE affects the neck/head (in 40% of 
cases), trunk (in 30%) or extremities (in 30%). Numerous case reports have identified the 
lesion in noncutaneous locations, including the bone, mediastinum and peritoneum. The 
tumors are usually solitary; however, multifocal disease has been reported. Metastatic 
disease has not been reported [4, 5]. 
Mortality is high and ranges from 10 to 14%, with a significantly higher rate for deep 
soft-tissue or visceral lesions occurring in infants younger than 6 months [6]. 
More than 50% of KHE cases are associated with a Kasabach-Merritt phenomenon, a 
condition characterized by thrombocytopenia and hypofibrinogemia with elevated markers 
of coagulation activation such as D-dimers or fibrin-degradation products; this association is 
known as KMS. KHE can be diagnosed by physical examination and medical history [6]. 
KMS is typically associated with more aggressive lesions and poorer outcomes [7]. 
Death most often results from expansive tumor growth and life-threatening hemorrhage 
[8, 9]. The lesion is typically an ill-defined, red-to-purple indurate plaque; ecchymosis can 
be seen with or without teleangectasia and the lesions can have hypertricosis. The tumor 
may spontaneously decrease in size with time; however, complete regression is uncom-
mon [6]. 
Characteristic imaging features may aid in the diagnosis of KHE. Magnetic resonance 
imaging is the modality of choice for the evaluation of tumor infiltration and expansion. 
Resonance angiography may better define arterial supply and venous drainage of the 
tumor. Computed tomography, ultrasound and radiographs are of limited usefulness in the 
evaluation of KHE [5]. On histological examination, the lesion is composed of infiltrating 
nodules with slit or crescent-like vessels that are poorly canalized and lined by spindled 
endothelium cells [1]. In our case, the patient had KMS based on the presentation and 
clinical findings. We performed CT angiography at the first admission due to the critical 
condition of the baby. Magnetic resonance imaging was done once her clinical condition had 
stabilized. 
Due to the rarity of this lesion, there is no consensus on ‘the best treatment’. Surgical 
excision is recommended when feasible [5]. Most patients with KHE present an infiltrating 
lesion, involving multiple tissue planes, nerves, blood vessels and other important struc-
tures; this presents a contraindication for surgery. Medical treatment is mandatory in the 
presence of KMS or when surgery is not possible; this includes chemotherapy (vincristine, 
actinomycin and cyclophosphamide), corticosteroids, interferon alpha, antiplatelet and 
antifibrinolytic agents and propanolol [10, 11]. Radiation therapy has also been described as 
being successful for KHE [1, 12]. Percutaneous embolization is performed in some types of 
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vascular lesions, but is not recommended for the very young [4]. Embolization has been used 
to treat vascular tumors, but its indication and success in newborns with KHE and KMS are 
scarce [6]. The challenging percutaneous technique presents with unique aspects in 
neonates and small babies. 
Experience in pediatric endovascular interventions is mandatory in order to avoid com-
plications [6, 13, 14]. Very thin catheters are required to accomplish both angiography and 
embolization. Catheterization time must be very short to preserve the future patency and 
growth of the accessed and contralateral limb [3]. As for the contrast material, small 
amounts (up to 6 ml/kg body weight) may be used without adverse effects. 
In our case, embolization was adopted as part of a more complicated surgical procedure, 
not only to decrease the flow of the vascular tumor but also to achieve a complete occlusion. 
Particulate embolic agents are well-suited to achieve this goal, but the use of liquid embolic 
agents has also been reported [3, 13–15]. Both types were used in our case according to the 
specific angioarchitecture of the vascular tumors. Whereas reabsorbable gelatin sponge 
material in the hypogastric district may be injected with the aid of a portable C-arm tube, the 
embolization with nonadhesive, nonacrylic, liquid polymer agent Onyx-18 does require a 
high-level fluoroscopy control to avoid nontarget embolization. The microcatheter must be 
compatible with dimethyl sulfoxide, the solvent used for the dilution and delivery of Onyx-
18. The main advantages of Onyx-18 are its nonadhesive properties and radiopacity which 
allow more precise embolization. In addition, its greater biocompatibility causes less 
reactive inflammation than acrylic glues, thereby facilitating subsequent surgical resection if 
this has been planned [14, 15]. In our case, the injection of 0.8 ml of Onyx-18 was followed 
by an uneventful recovery. Surgical isolation of the artery in small babies and its emboliza-
tion after securing the arterial branches reduce the risks of perforation and artery intimal 
dissection of the percutaneous technique. Postoperative pulse oximetry, continuous 
monitoring of the electrocardiogram and pressure and control of body temperature were 
conducted and these should be mandatory. The safety of the hybrid approach may extend 
the indications for imaging-guided embolization in small babies. Many possible different 
surgical approaches and materials for embolizing the pathologic targets should be consid-
ered. 
Conclusion 
When complete surgical removal is not possible or is contraindicated and medical 
treatment is not satisfactory, a combined therapy is mandatory. In our experience, chemo-
therapy and endovascular embolization by surgical approach seem most adequate in 
neonates and small infants in cases of infiltrating, unresectable, life-threatening tumors. 
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Fig. 1. Abdominopelvic hemangioendothelioma before chemotherapy. a CT scan: coronal view showing 
bladder displacement. b CT scan: main vascular mass supply. 
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Fig. 2. Postembolization contrast CT study showing total devascularization and regression of the pelvic 
lesion. 
 
 
 
Fig. 3. Imaging findings. a Angiographic aspect: tumor occupying the left thigh before embolization.  
b Limb angiography: main feeder of remaining tumor of the gluteus. c Fluoroscopy: selective catheteriza-
tion of the profunda femoris artery. Onyx-18 injection. 
 
